Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real‐world study

Key Points

• The aim of the research is to assess the effectiveness and safety of lecanemab in the Chinese Alzheimer's disease population.
• Multicenter real-world study
• Evaluation of lecanemab efficacy and safety
• Measure plasma p-tau217 levels as a biomarker
• Lecanemab was effective in treating Alzheimer's disease in the observed population
• Lecanemab was well tolerated by patients
• Plasma p-tau217 shows potential as a treatment-response biomarker

Abstract